Clinical Trial Update: Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital

View source ↗

Summary

The study evaluated switching patients from original infliximab to its biosimilar in daily practice at Cochin Hospital, across rheumatoid arthritis, spondyloart…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Rheumatoid Arthritis
• Spondyloarthritis
• Uveitis

Drugs mentioned

• INFLECTRA (infliximab-dyyb)
• Remicade (infliximab)
• Remsima (infliximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Rheumatoid Arthritis, Spondyloarthritis | Status: COMPLETED